A Young Man with Lymphocytosis

Kassirer J.P. , Kopelman R.I. . Learning Clinical Reasoning. Baltimore, Md: Williams and Wilkins; 1991.

International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging and response criteria. Ann Intern Med. 1989; 110: 236–238.

Faguet G.B. . Chronic lymphocytic leukemia: an updated review. J Clin Oncol. 1994; 12: 1974–1990.

O'Brien S. , del Giglio A. , Keating M. . Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood. 1995; 85: 307–318.

Pauker S.G. , Kopelman R.I. . Some familiar trade-offs. N Engl J Med. 1994; 331: 1511–1514.

Djulbegovic B. . Chronic myelogenous leukemia. In: Djulbegovic B. , ed. Reasoning and Decision Making in Hematology. New York, NY: Churchill Livingstone; 1992: 113–116.

Zittoun R.A. , Mandell F. , Willemze R. . Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med. 1995; 332: 217–223.

French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. Blood. 1990; 75: 1414–1421.

Rozman C. , Montserrat E. . Critical factors in new therapeutic approaches in chronic lymphocytic leukemia. Nouv Rev Fr Hematol. 1988; 30: 453–455.

Montserrat E. , Vinolas N. , Reverter J.C. . Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol. 1988; 30: 359–361.

Molica S. . Progression and survival studies in early chronic lymphocytic leukemia. Blood. 1991; 78: 895–899.

Montserrat E. , Gomis F. , Vallespi T. . Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood. 1991; 78: 1545–1551.

Dighiero G. , Travade P. , Chevret S. . B-cell chronic lymphocytic leukemia: present status and future directions. Blood. 1991; 78: 1901–1914.

Rozman C. , Montserat E. . Chronic lymphocytic leukemia. N Engl J Med. 1995; 333: 1055–1057.

Djulbegovic B. . An estimation of life expectancy: the method is a message. Med Decis Making. 1993; 13: 245–246.

French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. Blood. 1990; 75: 1422–1425.

French Cooperative Group on Chronic Lymphocytic Leukemia. Effectiveness of “CHOP” regimen in advanced untreated chronic lymphocytic leukaemia. Lancet. 1986; 1: 1346–1349.

Rai K.R. , Kalra J. . Chronic lymphocytic leukemia. In: Brain M.C. , Carbone P.P. , eds. Current Therapy in Hematology-Oncology. 5th ed. St. Louis, Mo: Mosby; 1995: 251–254.

Gunz F.W. . Treatment of chronic leukemias. In: Hoogstraten B. , ed. Hematologic Malignancies. Berlin: Springer-Verlag; 1986: 1–15.

Gale R.P. , Foon K.A. . Chronic lymphocytic leukemia: recent advances in biology and treatment. Ann Intern Med. 1985; 103: 101–120.

Keating M.J. , O'Brien S. , Kantarjian H. . Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood. 1993; 81: 2878–2884.

Robertson L.E. , Huh Y.O. , Butler J.J. . Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood. 1992; 80: 29–36.

Rai K.R. , Peterson B. , Kolitz J. . Fludarabine induces a high complete remission rate in previously untreated patients with active chronic lymphocytic leukemia (CLL): a randomized intergroup study. Blood. 1995; 86: s2414.

O'Brien S. , Kantarjian H. , Estey E. . Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. N Engl J Med. 1994; 330: 319–322.

Bell D.E. . Disappointment in decision making under uncertainty. In: Bell D.E. , Raiffa H. , Tversky A. , eds. Decision Making: Descriptive, Normative and Prescriptive Interactions. Cambridge, Mass: Cambridge University Press; 1988: 358–383.

Djulbegovic B. , Hozo I. , Schwartz A. . Acceptable regret in medical decision making. Med Hypotheses. 1999. In press.

Pavletic Z.S. , Bierman P.J. , Vose J.M. . High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. Ann Oncol. 1998; 9: 1023–1026.

Michallet M. , Corront B. , Hollard D. . Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG. Bone Marrow Transplant. 1991; 7: 275–279.

Bandini G. , Michallet M. , Rosti G. . Bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant. 1991; 7: 251–253.

Rabinowe S.N. , Soiffer R.J. , Gribben J.G. . Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood. 1993; 82: 1366–1376.

Michallet M. , Archimbaud E. , Bandini G . HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med. 1996; 24: 311–315.

Khouri I.F. , Przepiorka D. , van Besien K. . Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol. 1997; 97: 446–473.

Pavletic Z.S. , Arrowsmith E.R. , Bierman P.J. . Allogenic stem cell transplantation from related or unrelated donors for B-cell chronic lymphocytic leukemia. Blood. 1998; 92: 288a.

Djulbegovic B. . Chronic lymphocytic leukemia. In: Djulbegovic B. , Sullivan D.M. eds Decision Making in Oncology: Evidence-based Management. New York, NY: Churchill Livingstone; 1997: 45–52.

Mehta J. , Powles R. , Singhai S. . T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure. Bone Marrow Transplant. 1996; 17: 881–883.

Howe C.W.S. , Radde-Stepaniak T. . Hematopoietic cell registries. In: Thomas E.D. , Blume K.G. , Forman S.J. , eds. Hematopoietic Cell Transplantation. Malden, Mass: Blackwell; 1998: 503–512.

Lee S.J. , Kuntz K.M. , Horowitz M.M. . Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Ann Intern Med. 1997; 127: 1080–1088.

Vital Statistics of the United States (annual). Washington, DC: US National Center for Health Statistics.

Rowe J.M. , Ciobanu N. , Ascensao J. . Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation: a report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med. 1994; 120: 143–158.

Greenberg D.L. , Root R.K. . Clinical problem-solving. Decision making by analogy. N Engl J Med. 1995; 332: 592–596.

Albert D.A. , Munson R. , Resnik M.D. . Reasoning in Medicine: An Introduction to Clinical Inference. Baltimore, Md: The John Hopkins University Press; 1988: 92–93.

Evidence-based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA. 1992; 268: 2420–2425.

Sackett D.L. , Richardson W.S. , Rosenberg W. . Evidence-Based Medicine: How to Practice and Teach EBM. New York, NY: Churchill Livingstone; 1997.

Djulbegovic B. , Loughran T.P. , Hornung C.A. . The quality of medical evidence in hematology-oncology. Am J Med. 1999; 106: 198–205.

Redelmeier D.A. , Tversky A. . Discrepancy between medical decisions for individual patients and for groups. N Engl J Med. 1990; 322: 1162–1164.

American College of Physicians Ethics Manual, third edition. Ann Intern Med. 1992; 117: 947–960.